Daewoong Pharmaceutical said on Friday that it has completed the deployment of thynC, an AI-powered smart bed monitoring system, at Chonnam National University Hospital and Chonnam National University Hwasun Hospital. The project covers a total of 558 hospital beds, 217 at Chonnam National University Hospital and 341 at Chonnam National University Hwasun Hospital, making it the largest thynC installation among Korea's national university hospitals. The initiative is expected to accelerate the transition toward smart wards at major tertiary hospitals across the Honam region, the company said.
thynC is a smart bed monitoring platform that continuously collects patients' vital signs via wearable devices and integrates the data into a centralized ward-level monitoring system. The platform analyzes key physiological parameters in real time and immediately alerts healthcare providers when abnormal signs are detected, enabling faster clinical decision-making and emergency response.
Chonnam National University Hospital is a regional emergency medical center responsible for treating critically ill and emergency patients in the Gwangju and South Jeolla areas. It plans to implement thynC primarily in departments with a high concentration of emergency admissions and critically ill patients, including cardiology, neurology, and emergency medicine. The hospital is also pursuing the construction of a 1 trillion-won ($650 million) New Smart Hospital, and the thynC deployment is viewed as a significant step toward establishing the digital healthcare infrastructure needed for the future facility.
Chonnam National University Hwasun Hospital, a specialized cancer center ranked among the world's leading oncology hospitals in Newsweek's global rankings, has deployed thynC in key wards where patients undergoing highly complex treatments are concentrated, including medical oncology, hematology, and surgery. Because cancer patients can experience rapid deterioration due to complications such as infections and sepsis, early detection of warning signs is critical, and hospital officials expect the system to enhance patient safety and clinical efficiency through continuous monitoring and early intervention.
"This thynC deployment represents another step forward in strengthening patient safety at a leading tertiary hospital responsible for treating critically ill patients throughout the Gwangju and Jeonnam region," said Jung Shin, president of Chonnam National University Hospital. Lee Wan-sik, president of Chonnam National University Hwasun Hospital, said: "As a globally recognized cancer hospital that treats a large number of patients requiring highly complex care, real-time patient monitoring is essential." Lee Young-shin, CEO of SEERS, said the company will continue to enhance thynC's clinical utility by incorporating the needs of healthcare professionals in real-world medical settings.